South African based Trinity Pharma, part of the TriVest Group, is a registered Pharmaceutical company committed to promoting affordable and high quality Pharmaceutical products and services in Sub-Saharan Africa. This is done by partnering with leading international and local pharmaceutical companies.
By partnering with leading European, North American and Asian principals Trinity Pharma offers access to African markets through their regulatory consultancy services and/or product commercialisation capabilities. Trinity Pharma supplies generics to the largest pharmaceutical retailers in South Africa, and ultimately Africa. Effectively, they service the entire range of Healthcare products through their extensive industry experience, knowledge, networks and partnerships.
As a fully licensed pharmaceutical company you, as a client, can benefit from the many specialised services and opportunities offered in the dynamic healthcare environment. Trinity Pharma ensures the most efficient route to market for their clients. Some of their services include:
Modular service offering:
Contact
Oval Business Park
Wanderers Building
Cnr Sloane and Meadowbrook Close
Bryanston
2194
South Africa
Tel: +27 (0)10 594 5610
Fax: +27 (0)12 664 2452
http://www.trinitypharma.co.za/
The managing director of Trinity Pharma, Gaby Simaan (Jnr) depicts Trinity’s evolution from a regulatory consultancy into a fully commercialized pharmaceutical company, and how their unique position in the private…
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
See our Cookie Privacy Policy Here
